These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32405591)

  • 1. Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy.
    Lee T; Chung Y; Poulton CJ; Derebail VK; Hogan SL; Reich HN; Falk RJ; Nachman PH
    Kidney Int Rep; 2020 May; 5(5):706-717. PubMed ID: 32405591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.
    Thompson A; Cattran DC; Blank M; Nachman PH
    J Am Soc Nephrol; 2015 Dec; 26(12):2930-7. PubMed ID: 26078365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria.
    He P; Zha Y; Liu J; Wang H; He L
    Front Med (Lausanne); 2021; 8():737700. PubMed ID: 34926493
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous Nephropathy: Quantifying Remission Duration on Outcome.
    Cattran DC; Kim ED; Reich H; Hladunewich M; Kim SJ;
    J Am Soc Nephrol; 2017 Mar; 28(3):995-1003. PubMed ID: 27756808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
    BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical covariates influencing clinical outcomes in primary membranous nephropathy.
    Westermann L; Rottmann FA; Hug MJ; Staudacher DL; Wobser R; Arnold F; Welte T
    BMC Nephrol; 2023 Aug; 24(1):235. PubMed ID: 37563703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of associated factors for remission and relapse in proliferative and membranous lupus nephritis patients: a 4-year follow-up study].
    Qi CJ; Ye BX; Ni ZH; Cao LO; Zhang MF; Mou S; Wang Q; Yan YC; Fang W; Zhu ML; Lu RH; Qian JQ
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3826-30. PubMed ID: 24548442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; Pisano L; D'Amico G
    Am J Kidney Dis; 2001 Aug; 38(2):240-8. PubMed ID: 11479148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
    Teisseyre M; Cremoni M; Boyer-Suavet S; Crepin T; Benzaken S; Zorzi K; Esnault V; Brglez V; Seitz-Polski B
    Front Immunol; 2021; 12():738788. PubMed ID: 34721403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic membranous nephropathy: definition and relevance of a partial remission.
    Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
    Kidney Int; 2004 Sep; 66(3):1199-205. PubMed ID: 15327418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.
    Stoycheff N; Stevens LA; Schmid CH; Tighiouart H; Lewis J; Atkins RC; Levey AS
    Am J Kidney Dis; 2009 Nov; 54(5):840-9. PubMed ID: 19556043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.
    Michel PA; Dahan K; Ancel PY; Plaisier E; Mojaat R; De Seigneux S; Daugas E; Matignon M; Mesnard L; Karras A; François H; Pardon A; Caudwell V; Debiec H; Ronco P
    Nephron Extra; 2011 Jan; 1(1):251-61. PubMed ID: 22470399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis.
    Zhong H; Li HY; Zhou T; Zhong Z
    Arch Med Sci; 2023; 19(2):411-419. PubMed ID: 37034519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal Medicine "Shulifenxiao" Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy.
    Cui H; Fu FQ; Liu B; Liu WJ; Liu YN
    Front Pharmacol; 2021; 12():675406. PubMed ID: 34040535
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
    Li S; Wang L; Zhang M; Zhou W; Fang W; Wang Q; Qi C; Mou S; Shao X; Ni Z
    Nephron; 2017; 135(2):87-96. PubMed ID: 27974710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.